Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,873–2,880 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Nektar Therapeutics Rezpegaldesleukin (LY3471851 or REZPEG) Systemic lupus erythematosus (SLE) Phase 2 Trial Discontinued Subcutaneous Immunology
NeOnc Technologies Holdings Inc. NEO100-01 Glioblastoma (GBM) Phase 2 Ongoing Inhalation Oncology
NeOnc Technologies Holdings Inc. NEO212 Newly diagnosed gliomas Phase 2a Trial Planned Oral Oncology
Neumora Therapeutics Inc. Navacaprant (NMRA-140) - (KOASTAL-1) Major depressive disorder Phase 3 Data Released Oral Psychiatric
Neumora Therapeutics Inc. Navacaprant (NMRA-140) - (KOASTAL-1) Major depressive disorder Phase 3 Data Released Oral Psychiatric
Neumora Therapeutics Inc. Navacaprant (NMRA-140) Bipolar Depression Phase 2 Ongoing oral Psychiatric
Neuphoria Therapeutics Inc. BNC210 - (AFFIRM-1) Social Anxiety Disorder (SAD) Phase 3 Data Released oral Psychiatric
Neurocrine Biosciences Inc. Osavampator (NBI-1065845) - (SAVITRI) Major depressive disorder Phase 3 Ongoing Oral Psychiatric